MicroAire appoints Remco Maljers as Head of International Sales
Remco brings with him extensive experience in global market expansion, a vast network of healthcare professionals worldwide, and a proven track record for driving revenue growth. He draws on over 25 years of experience in medical device business development, including leadership positions at Medtronic, Wright Medical, and NuVasive. During his most recent tenure at Orthofix, Remco spearheaded market expansion efforts across Central and
In his new role, Remco will report directly to MicroAire's president. He will lead commercial efforts outside
"I am extremely pleased to welcome Remco to MicroAire and am confident in his ability to propel the company to new heights in our international markets," said
About MicroAire
Since its first product launch in 1977, MicroAire has been dedicated to designing and manufacturing innovative surgical instruments. This dedication led to the creation of industry-leading devices for body contouring and treating Carpal Tunnel Syndrome and propels MicroAire employees forward every day to empower surgeons and deliver better patient outcomes. MicroAire is a part of Marmon Holdings, Inc., a Berkshire Hathaway company.
Media Contact
Senior Director, Strategy & Customer Excellence
MicroAire Surgical Instruments
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/microaire-appoints-remco-maljers-as-head-of-international-sales-302349491.html
SOURCE MicroAire
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parksy.com Free Driver Tools In One App: Fine Appeals, Sign Scanning, Car Finding and Crash Reports
- Is AI Car Diagnostics Worth It for DIY Owners? Tyler-powered THINKCAR Scanners Give DIYers a Diagnostic Solution
- Invisalign Clear Aligners Explained for Teens and Adults
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Warren BuffettSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share